TRIMT and TETRAKIT

October 10, 2022

TRIMT and TETRAKIT

#TRIMT and #TETRAKIT are joining forces to develop 18F-Flutrahexin based on #Nobel Prize awarded #technology. Read more in the press release.

About TRIMT   TRIMT GmbH is a clinical-stage company developing novel radiopharmaceuticals to diagnose and treat life-threatening diseases. The company was founded in early 2021 in Radeberg near Dresden (Germany). TRIMT holds a worldwide exclusive license for various new radioligands based on technologies from the Technical University of Munich.

TetraKit will be at the EANM
We’re thrilled to share that TetraKit will be at the 38th Annual Congress of the European Association of Nuclear Medicine (EANM), taking place in Barcelona, Spain from October 4–8, 2025. Matt… Read more
Leadership reshuffling at TetraKit Technologies
We’re excited to announce a leadership reshuffling at TetraKit Technologies. This change will support our continued growth as we move into the next phase of development🔬… Read more
Our radiochemistry laboratory has been fully operational since July
We are excited to share that our radiochemistry laboratory has been fully operational since July 🎉 including work with astatine-211. This is a major achievement for the Department of Drug Design … Read more
TetraKit Technologies Logo

TetraKit Technologies ApS
Ole Maaløes Vej 3, DK-2200 Copenhagen Denmark

About:

About Company Partnerships Funding

Science:

Platform Pipeline

Other:

News Team Contact Careers

Legal:

Privacy Policy

Connect with us:

© 2022 TetraKit Technologies. All rights reserved